Abbott Buys Facet Biotech to Enhance Pipeline
By PharmaDeals Analyst
Pharma Deals Review: Vol 2010 Issue 3 (Table of Contents)
Published: 31 Mar-2010
DOI: 10.3833/pdr.v2010.i3.1322 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Abbott and Facet Biotech have signed an agreement to acquire the latter in a deal valued at USD 450 M; adding to its biologics capability and pipe line in both oncology and immunology...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS